Net sales grew 25% year-over-year (30% at CER), driven by strong US and EUROW performance, with adjusted operating margin reaching 29%. Updated FY 2026 guidance forecasts 33–36% net sales growth at CER. Cash position remains strong after share buy-back.Original document: BONESUPPORT HOLDING AB [BON…
Net sales grew 25% year-over-year (30% at CER), driven by strong US and EUROW performance, with adjusted operating margin reaching 29%. Updated FY 2026 guidance forecasts 33–36% net sales growth at CER. Cash position remains strong after share buy-back.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.